General Information of the Compound
Compound ID
CP0853710
Compound Name
(3aR,9bS)-6-methyl-2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-one hydrochloride
    Show/Hide
Structure
Formula
C12H15ClN2O
Molecular Weight
238.718
Canonical SMILES
Cc1cccc2c1C(=O)N[C@H]1CNC[C@H]21.Cl
    Show/Hide
InChI
InChI=1S/C12H14N2O.ClH/c1-7-3-2-4-8-9-5-13-6-10(9)14-12(15)11(7)8;/h2-4,9-10,13H,5-6H2,1H3,(H,14,15);1H/t9-,10+;/m1./s1
    Show/Hide
InChIKey
CCFJJHFDZNFADQ-UXQCFNEQSA-N
Physicochemical Property
logP
1.21562
Rotatable Bonds
0
Heavy Atom Count
16
Polar Areas
41.13
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11514225
SID: 16616152
ChEMBL ID
CHEMBL2337494
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 127 nM
   TI
   LI
   LO
   TS
2
Ki = 56 nM
   TI
   LI
   LO
   TS
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 94 nM
   TI
   LI
   LO
   TS
2
Ki = 23 nM
   TI
   LI
   LO
   TS
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 1.1 nM
   TI
   LI
   LO
   TS
2
Ki = 3.9 nM
   TI
   LI
   LO
   TS